H1N1 influenza circulating in India is cause for concern Mylan launches generic Subutex FDA publishes bio-equivalence guidance documents Actavis launches generic Temovate cream Teva sells Sellersville, Penn., facility to G&W Labs Impax completes two acquisitions, reshapes division structure ANI acquires generic product from Teva Apple turns iPhone into powerful medical research tool with new source code Mylan closes deal on Abbott Laboratories' non-U.S. developed markets specialty and branded generics business NY legislators green light delay of e-prescribing mandate First Previous 321 322 323 324 325 Next Last